NCT02030535 - Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

olodaterol

free combination with tiotropium

DRUG

tiotropium

free combination with olodaterol

DRUG

Placebo

DRUG

tiotropium

fixed dose combination with olodaterol

DRUG

olodaterol

fixed dose combination with tiotropium

Trial Locations (6)

1237.7.49004 Boehringer Ingelheim Investigational Site, Berlin

1237.7.49005 Boehringer Ingelheim Investigational Site, Berlin

1237.7.49007 Boehringer Ingelheim Investigational Site, Frankfurt

1237.7.49002 Boehringer Ingelheim Investigational Site, Großhansdorf

1237.7.49003 Boehringer Ingelheim Investigational Site, Hamburg

1237.7.49001 Boehringer Ingelheim Investigational Site, Weinheim